Identity
- Trade Name
- Syva® Emit® 2000 Digoxin Calibrators FDA UDI
- Generic Name
- Digoxin therapeutic drug monitoring IVD, calibrator FDA UDI
- Device Name
- Emit ® 2000 Digoxin Calibrators FDA UDI
- Model / Reference
- 10445316 FDA UDI
- Description
- Emit ® 2000 Digoxin Calibrators FDA UDI
Identifiers
- Catalog Number
- 4H209UL FDA UDI
- Primary DI / UDI-DI
- 00842768000973 FDA UDI
- 510(k) Number
- K934135 FDA UDI
- FDA Product Code
- KXT FDA UDI
- GMDN Term
- Digoxin therapeutic drug monitoring IVD, calibrator FDA UDI
Classification
- Device Class
- Class II FDA UDI
- Regulation Number
- 862.3320 FDA UDI
- Commercial Distribution
- In Commercial Distribution FDA UDI
Clinical & Handling
Sterile
No
FDA UDI
Single Use
No
FDA UDI
Implantable
No
FDA UDI
Contains Latex
No
FDA UDI
Prescription Use
No
FDA UDI
Over-the-Counter
No
FDA UDI
Convenience Kit
No
FDA UDI
Combination Product
No
FDA UDI
HCT/P
No
FDA UDI
Premarket Exempt
No
FDA UDI
Lot / Batch Number
Yes
FDA UDI
Serial Number
No
FDA UDI
Expiration Date
Yes
FDA UDI
Manufacturing Date
No
FDA UDI
Category: Digoxin therapeutic drug monitoring IVD, calibrator
Syva® Emit® 2000 Digoxin Calibrators by Siemens Healthcare Diagnostics — Class II — FDA UDI — listed in FDA GUDID — regulatory data on deviCERTS
Similar devices
Also classified as Digoxin therapeutic drug monitoring IVD, calibrator.
- Cobas Elecsys AntiTPO — Roche Diagnostics Corp. · Class II
- ARCHITECT — Abbott Laboratories, Inc. · Class II
- ARCHITECT — Abbott · Class II
- ARCHITECT — Abbott Laboratories, Inc. · Class II
Authorization Coverage (1 country)
Regulatory Authorizations
United States Pending data
FDA UDI
| Source | Region | Type | Cert / Approval No. | Class | Status |
|---|---|---|---|---|---|
| FDA UDI | United States | FDA UDI | Registered in GUDID | Class II | Pending data |
Is this your device? Claim it to add documentation and request validation.
Manufacturer
- Manufacturer
- Siemens Healthcare Diagnostics
Sources (1)
- FDA UDI e3a73df3-52c8-484e-ada3-b556882a19d0 37 fields · synced May 30, 2026